P.O. Box 69
164 articles with Getinge
In total, sales increased by 3.6% organically compared with the second quarter 2020, and the order intake declined by 6.1% organically compared with 2020 when we received very large orders of advanced ICU ventilators.
Getinge now introduces Torin with AI in the United States.
Getinge has launched a new framework for social financing and a new social bond of SEK 570 million. The capital will be used to expand the production capacity of products that save lives.
Three out of four Getinge employees who have worked from home during the COVID-19 pandemic believe that the setup has improved their productivity as well as their work-life harmony.
Orange Business Services Flexible SD-WAN Supports Getinge With Increased Agility to Aid the Health Industry
Getinge, a leading global supplier of medical technology products and systems, chose Orange Business Services to deploy a software-defined wide area network.
NICCI is Getinge's latest innovation in Advanced Hemodynamic Monitoring, providing continuous and noninvasive hemodynamic insights to reduce the risk of severe complications for patients with low blood pressure
Together with leading industry partners, Getinge is showcasing innovative connectivity solutions for creating a more quiet and healing environment for the intensive care unit.
Getinge announces its intention to become a CO₂neutral company by 2025. The target will be reached by a stepwise approach in several areas and supports the company's objective to contribute to a sustainable health care environmentally as well as socially.
During this year's second quarter, we report a continued strong order intake and net sales of advanced ICU ventilators and ECMO therapy products for hospitals and Sterile Transfer products for the pharmaceutical industry," says Mattias Perjos, President & CEO Getinge.
US Food & Drug Administration (FDA) clears Servo-air® mechanical ventilator for use with adult and pediatric patients dependent on intensive care ventilation expanding upon the Servo family of products available in the United States for decades. "FDA 510(k) clearance for Servo-air will broaden our US offering with a turbi
Getinge Interim Report for January-March 2020: Intense Efforts to Help Hospitals in the COVID-19 Pandemic
The quarter was dominated by the COVID-19 pandemic and the huge need for advanced ventilators and ECMO therapy at intensive care units around the world.
Getinge introduces one of its latest connectivity solutions for acute care products.
Getinge Contributes to Ventilator Manufacturers Group to Form Ventilator Training Alliance and Create App to Help Frontline Medical Workers During COVID-19 Pandemic
Several of the world's ventilator manufacturers announce a newly formed Ventilator Training Alliance to support frontline medical providers to access a centralized repository of ventilator training.
Getinge, the world market leader in advanced ventilators for intensive care units, is announcing yet another ramp-up in production capacity, to 26,000 ventilators in 2020. The increase equals a growth of 160% compared to 2019, when 10,000 ventilators were produced. The demand for advanced ventilators for the intensive care
Getinge and WaterAid Partner up to Strengthen Access to Clean Water, Sanitation and Hygiene at Health Care Facilities Around the World
Getinge announces a partnership with the international organization WaterAid.
Getinge Increases Production Capacity of Ventilators with 60% to Support the Needs of Global Intensive Care Units
Getinge has since the outbreak of the COVID-19 pandemic seen an increased global demand for ventilators, extra corporeal life support equipment and advanced monitoring for Intensive Care Units.
"Our organic sales growth continued in the fourth quarter and it was particularly good to see the strong performance of our three largest markets - the US, China and Germany," says Mattias Perjos, President & CEO at Getinge.
Getinge to Acquire Applikon Biotechnology B.V., A Leading Company in the Fast Growing Area of Bioreactor Systems
Getinge announces an agreement to acquire 100% of the shares in Applikon Biotechnology B.V. from Applikon Biotechnology Holding B.V.
We continue to show strong organic sales growth and improved margins in the third quarter", says Mattias Perjos, President & CEO at Getinge.
The inclination of patients and surgeons toward MI procedures using thoracic catheters is increasing significantly owing to the severe complications associated with traditional open surgeries.